Decellularized scaffolds in regenerative medicine
- PMID: 27486772
- PMCID: PMC5295461
- DOI: 10.18632/oncotarget.10945
Decellularized scaffolds in regenerative medicine
Abstract
Allogeneic organ transplantation remains the ultimate solution for end-stage organ failure. Yet, the clinical application is limited by the shortage of donor organs and the need for lifelong immunosuppression, highlighting the importance of developing effective therapeutic strategies. In the field of regenerative medicine, various regenerative technologies have lately been developed using various biomaterials to address these limitations. Decellularized scaffolds, derived mainly from various non-autologous organs, have been proved a regenerative capability in vivo and in vitro and become an emerging treatment approach. However, this regenerative capability varies between scaffolds as a result of the diversity of anatomical structure and cellular composition of organs used for decellularization. Herein, recent advances in scaffolds based on organ regeneration in vivo and in vitro are highlighted along with aspects where further investigations and analyses are needed.
Keywords: decellularized scaffold; extracellular matrix; in vivo/in vitro; organ; regeneration.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
References
-
- Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60–66. - PubMed
-
- Omar B, Shahrzad A, Gabriela R, Jessie R, R Patrick W, Claire O, Holley LS, Gauthier PK. Use of Decellularized Porcine Liver for Engineering Humanized Liver Organ. Journal of Surgical Research. 2011;173:e11–25. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
